S Viskin1, R Fish, M Eldar, D Zeltser, M D Lesh, A Glick, B Belhassen. 1. Department of Cardiology, Sourasky-Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Weizman 6, Tel Aviv 64239, Israel. viskin@netvision.net.il
Abstract
OBJECTIVE: To determine the prevalence of the Brugada sign (right bundle branch block with ST elevation in V1-V3) in idiopathic ventricular fibrillation and in an age matched healthy population. DESIGN: ECGs from 39 consecutive patients with idiopathic ventricular fibrillation and 592 healthy controls were reviewed. They were classified as definite, questionable, and no Brugada sign (according to predetermined criteria) by four investigators blinded to the subjects' status. RESULTS: Eight patients (21%) with idiopathic ventricular fibrillation but none of the 592 controls had a definite Brugada sign (p < 0.005). Thus the estimated 95% confidence limits for the prevalence of a definite Brugada sign among healthy controls was less than 0.5%. A questionable Brugada sign was seen in two patients with idiopathic ventricular fibrillation (5%) but also in five controls (1%) (p < 0.05). Normal ECGs were found following resuscitation and during long term follow up in 31 patients with idiopathic ventricular fibrillation (79%). Patients with idiopathic ventricular fibrillation and a normal ECG and those with the Brugada syndrome were of similar age and had similar spontaneous and inducible arrhythmias. However, the two groups differed in terms of sex, family history, and the incidence of sleep related ventricular fibrillation. CONCLUSIONS: A definite Brugada sign is a specific marker of arrhythmic risk. However, less than obvious ECG abnormalities have little diagnostic value, as a "questionable" Brugada sign was observed in 1% of healthy controls. In this series of consecutive patients with idiopathic ventricular fibrillation, most had normal ECGs.
OBJECTIVE: To determine the prevalence of the Brugada sign (right bundle branch block with ST elevation in V1-V3) in idiopathic ventricular fibrillation and in an age matched healthy population. DESIGN: ECGs from 39 consecutive patients with idiopathic ventricular fibrillation and 592 healthy controls were reviewed. They were classified as definite, questionable, and no Brugada sign (according to predetermined criteria) by four investigators blinded to the subjects' status. RESULTS: Eight patients (21%) with idiopathic ventricular fibrillation but none of the 592 controls had a definite Brugada sign (p < 0.005). Thus the estimated 95% confidence limits for the prevalence of a definite Brugada sign among healthy controls was less than 0.5%. A questionable Brugada sign was seen in two patients with idiopathic ventricular fibrillation (5%) but also in five controls (1%) (p < 0.05). Normal ECGs were found following resuscitation and during long term follow up in 31 patients with idiopathic ventricular fibrillation (79%). Patients with idiopathic ventricular fibrillation and a normal ECG and those with the Brugada syndrome were of similar age and had similar spontaneous and inducible arrhythmias. However, the two groups differed in terms of sex, family history, and the incidence of sleep related ventricular fibrillation. CONCLUSIONS: A definite Brugada sign is a specific marker of arrhythmic risk. However, less than obvious ECG abnormalities have little diagnostic value, as a "questionable" Brugada sign was observed in 1% of healthy controls. In this series of consecutive patients with idiopathic ventricular fibrillation, most had normal ECGs.
Authors: H Kasanuki; S Ohnishi; M Ohtuka; N Matsuda; T Nirei; R Isogai; M Shoda; Y Toyoshima; S Hosoda Journal: Circulation Date: 1997-05-06 Impact factor: 29.690
Authors: K Nademanee; G Veerakul; S Nimmannit; V Chaowakul; K Bhuripanyo; K Likittanasombat; K Tunsanga; S Kuasirikul; P Malasit; S Tansupasawadikul; P Tatsanavivat Journal: Circulation Date: 1997-10-21 Impact factor: 29.690
Authors: H Atarashi; S Ogawa; K Harumi; H Hayakawa; T Sugimoto; R Okada; M Murayama; J Toyama Journal: Am J Cardiol Date: 1996-09-01 Impact factor: 2.778
Authors: M Furuhashi; K Uno; K Tsuchihashi; D Nagahara; M Hyakukoku; T Ohtomo; S Satoh; T Nishimiya; K Shimamoto Journal: Heart Date: 2001-08 Impact factor: 5.994
Authors: Paulus Kirchhof; Lars Eckardt; Sascha Rolf; Hans-D Esperer; Matthias Paul; Thomas Wichter; Helmut U Klein; Günter Breithardt; Dirk Böcker Journal: Ann Noninvasive Electrocardiol Date: 2004-04 Impact factor: 1.468